Provectus Pharmaceuticals, Inc. (PVCT:OTCBB)

I read today's press release. Although I was quite impressed over the results in the one trial participant, it was just a bit promtional to announce the results in one trial participant. This release is being isssued proior to the release of a peer reviewed abstract in Melanoma Research. Read about Dr. Hersey here